Adma Biologics Stock Market Value
| ADMA Stock | USD 6.46 0.08 1.22% |
| Symbol | ADMA |
Is ADMA Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADMA Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ADMA Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ADMA Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ADMA Biologics.
| 03/26/2024 |
| 04/25/2024 |
If you would invest 0.00 in ADMA Biologics on March 26, 2024 and sell it all today you would earn a total of 0.00 from holding ADMA Biologics or generate 0.0% return on investment in ADMA Biologics over 30 days. ADMA Biologics is related to or competes with Atara Biotherapeutics, Fate Therapeutics, Sana Biotechnology, Caribou Biosciences, Arcus Biosciences, Tff Pharmaceuticals, and INmune Bio. ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-... More
ADMA Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ADMA Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ADMA Biologics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.16 | |||
| Information Ratio | 0.1329 | |||
| Maximum Drawdown | 10.03 | |||
| Value At Risk | (2.99) | |||
| Potential Upside | 4.21 |
ADMA Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ADMA Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ADMA Biologics' standard deviation. In reality, there are many statistical measures that can use ADMA Biologics historical prices to predict the future ADMA Biologics' volatility.| Risk Adjusted Performance | 0.1131 | |||
| Jensen Alpha | 0.4479 | |||
| Total Risk Alpha | 0.0974 | |||
| Sortino Ratio | 0.1479 | |||
| Treynor Ratio | (0.61) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ADMA Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ADMA Biologics Backtested Returns
ADMA Biologics appears to be somewhat reliable, given 3 months investment horizon. ADMA Biologics secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of return volatility over the last 3 months. We have found thirty technical indicators for ADMA Biologics, which you can use to evaluate the volatility of the firm. Please makes use of ADMA Biologics' Mean Deviation of 2.01, risk adjusted performance of 0.1131, and Semi Deviation of 1.91 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, ADMA Biologics holds a performance score of 13. The firm shows a Beta (market volatility) of -0.65, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning ADMA Biologics are expected to decrease at a much lower rate. During the bear market, ADMA Biologics is likely to outperform the market. Please check ADMA Biologics' standard deviation, treynor ratio, downside variance, as well as the relationship between the total risk alpha and value at risk , to make a quick decision on whether ADMA Biologics' price patterns will revert.
Auto-correlation | -0.7 |
Very good reverse predictability
ADMA Biologics has very good reverse predictability. Overlapping area represents the amount of predictability between ADMA Biologics time series from 26th of March 2024 to 10th of April 2024 and 10th of April 2024 to 25th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ADMA Biologics price movement. The serial correlation of -0.7 indicates that around 70.0% of current ADMA Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.7 | |
| Spearman Rank Test | -0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
ADMA Biologics lagged returns against current returns
Autocorrelation, which is ADMA Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ADMA Biologics' stock expected returns. We can calculate the autocorrelation of ADMA Biologics returns to help us make a trade decision. For example, suppose you find that ADMA Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ADMA Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ADMA Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ADMA Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ADMA Biologics stock over time.
Current vs Lagged Prices |
| Timeline |
ADMA Biologics Lagged Returns
When evaluating ADMA Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ADMA Biologics stock have on its future price. ADMA Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ADMA Biologics autocorrelation shows the relationship between ADMA Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in ADMA Biologics.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ADMA Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ADMA Biologics' short interest history, or implied volatility extrapolated from ADMA Biologics options trading.
Pair Trading with ADMA Biologics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ADMA Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADMA Biologics will appreciate offsetting losses from the drop in the long position's value.Moving together with ADMA Stock
| 0.63 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.71 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to ADMA Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ADMA Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ADMA Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ADMA Biologics to buy it.
The correlation of ADMA Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ADMA Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ADMA Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ADMA Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out ADMA Biologics Correlation, ADMA Biologics Volatility and ADMA Biologics Alpha and Beta module to complement your research on ADMA Biologics. For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for ADMA Stock analysis
When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
ADMA Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.